Answers are grounded in this paper and cite their sources.
Objective On dual-tracer positron emission tomography/computed tomography (PET/CT) with 2-deoxy-2-[¹⁸F]fluoro-D-glucose ([¹⁸F]FDG) and fibroblast activation protein inhibitor ([⁶⁸Ga]Ga-FAPI-04), discordant lesions (FDG+/FAPI-) in aggressive neuroendocrine neoplasms (NENs) are linked to shorter progression-free survival (PFS). This study evaluated the prognostic value of such lesions in comparison to histological fibroblast activation protein (FAP) expression from a clinically obtained biopsy and their impact on PFS. Methods 23 patients with aggressive NENs underwent both [¹⁸F]FDG and [⁶⁸Ga]Ga-FAPI-04 PET/CT as well as biopsy within a short period of time. PET parameters [standardized uptake values (SUV): SUVmax, SUVmean, SUVpeak] were measured, as were tumor volume (TV), and total lesion uptake (TLU = TV × SUVmean). FDG+/FAPI- lesions were identified. FAP expression was assessed immunohistochemically using the immunoreactive score (IRS-FAP). Correlations between PET metrics, IRS-FAP, and FDG+/FAPI- lesions were analyzed. Cox regression and log-rank test were used to evaluate associations with PFS. Results IRS-FAP correlated significantly with TV ([¹⁸F]FDG: p=0.0165; [⁶⁸Ga]Ga-FAPI-04: p = 0.0181) and TLU ([¹⁸F]FDG: p = 0.0170; [⁶⁸Ga]Ga-FAPI-04: p = 0.0253). There was no significant correlation for IRS-FAP with SUV parameters. FDG+/FAPI- lesions were found in 9/23 patients and associated with significantly shorter PFS (4 vs. 10 months, HR: 3.383, p = 0.0015). [¹⁸F]FDG-TV and [¹⁸F]FDG-TLU correlated with PFS, but IRS-FAP showed no significant association with either PFS or FDG+/FAPI- lesions. Conclusions FAP expression on immunohistochemistry obtained from a single biopsy site does not predict discordant PET/CT findings. In contrast, the presence of FDG+/FAPI- lesions is a strong prognostic factor for reduced PFS. Thus, dual-tracer PET/CT may offer superior risk stratification compared to single-lesion histological FAP assessment in aggressive NENs.
No takes yet. Share an insight, caveat, or question.
Jedamzik et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: